iifl-logo

Bio Medica Laboratories Ltd Company Summary

Add as a Preferred Source on Google
144
(2.42%)
Jun 30, 2026|05:37:38 PM

Bio Medica Laboratories Ltd Summary

Bio Medica Laboratories Limited was originally incorporated as a private limited Company with the name of Bio Medica Laboratories Private Limited vide certificate of Incorporation dated August 14, 2015, issued by Registrar of Companies, Gwalior. Further, the status got converted into a Public Company & name of the Company changed from Bio Medica Laboratories Private Limited to Bio Medica Laboratories Limited & Registrar of Companies, CPC has issued a new Certificate of Incorporation dated October 24, 2024.Company is engaged in the of manufacturing of Pharmaceutical Parenteral Formulations. It manufacture variety of products, comprising ethical drugs, generic drugs and over the-counter drugs (OTC) in the form of injectables namely Liquid Injections and Dry Powder Injections.

These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Company operates on a B2B business model through contract manufacturing and does not deal directly with the end users. It manufacture formulations for various companies according to their specific requirements and specifications for the type of formulation needed.

Additionally, it enter into agreements with them, allowing their name and address to be displayed on the packaging as Technical Collaborator or marketed by alongside the Companys name as the manufacturer.Company is planning the public issue by issuing an aggregate of 37,71,600 equity shares of face value Rs 10 each, comprising a fresh issue of 33,94,800 equity shares and 3,76,800 equity shares through offer for sale.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.